Even as Covid-19 vaccine prices generate much discussion in the country, American drugmaker Pfizer has said it has offered a “not-for-profit price” for its Covid-19 vaccine for the government immunisation programme.
During the pandemic situation worldwide, Pfizer has maintained that its priority would be to exclusively support governments through supply of its vaccine only for their immunisation programmes, a company spokesperson said. “This will be our approach in India as well.”
“For India, Pfizer has offered a not-for-profit price for its vaccine. We continue to be in discussions with the government and remain committed to make our vaccine available for deployment in India’s immunisation programme,” the company said.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.